Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Physician Associates challenge outdated licensing rules to accelerate care, expand access, and ease the healthcare provider ...

The American Heart Association’s PREVENT equations predict risk in subgroups of Asian and Hispanic people, a new study shows.

While ADHD medications continue to reduce the risk for self-harm, injury, and car crashes, recent expanded prescribing ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on high-certainty data, offering new options for those with mild to severe disease.

Delayed intracranial hemorrhage is uncommon in patients with mild traumatic brain injury receiving anticoagulant therapy, a study finds.

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Portugal fails to report mental health data of its incarcerated population to the World Health Organization, reflecting ...

Dr Heather McArthur describes how ASCO 2025 showcased new standards of care in triple-negative and HER2-positive settings.

Remote ischemic preconditioning does not reduce postoperative myocardial injury among patients undergoing high- or ...